221 related articles for article (PubMed ID: 10482005)
41. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome.
Cekmen M; Evereklioglu C; Er H; Inalöz HS; Doganay S; Türköz Y; Ozerol IH
Int J Dermatol; 2003 Nov; 42(11):870-5. PubMed ID: 14636202
[TBL] [Abstract][Full Text] [Related]
42. Memory T lymphocytes' adherence to interferon gamma-activated human dermal microvascular endothelial cells via E-selectin.
Lee KH; Chung KY; Koh YJ
J Dermatol Sci; 1995 Sep; 10(2):166-75. PubMed ID: 8534616
[TBL] [Abstract][Full Text] [Related]
43. Anti-vascular endothelial cell antibodies (AECA): comparison of two assay methods and clinical applications.
Meyer O; Kaiser P; Haim T; Edgell CJ; Pasquier C; de Bandt M; Bridey F; Sellak H; Lansaman J; Kahn MF
Rev Rhum Engl Ed; 1995 Dec; 62(11):737-47. PubMed ID: 8869215
[TBL] [Abstract][Full Text] [Related]
44. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon.
Leung DY; Collins T; Lapierre LA; Geha RS; Pober JS
J Clin Invest; 1986 May; 77(5):1428-35. PubMed ID: 3084559
[TBL] [Abstract][Full Text] [Related]
45. Antigen presentation by human dermal microvascular endothelial cells. Immunoregulatory effect of IFN-gamma and IL-10.
Vora M; Yssel H; de Vries JE; Karasek MA
J Immunol; 1994 Jun; 152(12):5734-41. PubMed ID: 8207203
[TBL] [Abstract][Full Text] [Related]
46. Soluble endothelial protein C receptor levels in Behçet patients with and without ocular involvement.
Yalçindağ FN; Batioğlu F; Ozdemir O; Cansizoğlu E; Eğin Y; Akar N
Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1603-8. PubMed ID: 18604550
[TBL] [Abstract][Full Text] [Related]
47. The expression of transmembrane and soluble CXCL16 and the relation with interferon-alpha secretion in patients with Behçet's disease.
Yilmaz S; Cinar M; Pekel A; Simsek I; Musabak U; Erdem H; Pay S
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):84-7. PubMed ID: 24064021
[TBL] [Abstract][Full Text] [Related]
48. Markers of vascular injury in Behçet's disease associated with retinal vasculitis.
Pivetti-Pezzi P; Priori R; Catarinelli G; Meroni PL; Federici AB; Abdulaziz M; Falco M; Valesini G
Ann Ophthalmol; 1992 Nov; 24(11):411-4. PubMed ID: 1476395
[TBL] [Abstract][Full Text] [Related]
49. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
50. [Antiphospholipid antibodies in Behcet's disease].
Alekberova ZS; Prokaeva TB; Reshetniak TM; Aleksandrova EN; Nasonov EL
Klin Med (Mosk); 2000; 78(5):37-8. PubMed ID: 10881508
[TBL] [Abstract][Full Text] [Related]
51. Studies of the modulation of MHC antigen and cell adhesion molecule expression on human dermal microvascular endothelial cells.
Swerlick RA; Garcia-Gonzalez E; Kubota Y; Xu YL; Lawley TJ
J Invest Dermatol; 1991 Aug; 97(2):190-6. PubMed ID: 1906507
[TBL] [Abstract][Full Text] [Related]
52. Caspase-9 expression is increased in endothelial cells of active Behçet's disease patients.
Oztaş P; Lortlar N; Polat M; Alli N; Omeroğlu S; Basman A
Int J Dermatol; 2007 Feb; 46(2):172-6. PubMed ID: 17269970
[TBL] [Abstract][Full Text] [Related]
53. Evidence that rat xenoreactive antibodies recognize multiple protein antigens on guinea pig endothelial cells and platelets.
Scherrer L; Leventhal JR; Matas AJ; Dalmasso AP
Transplantation; 1994 Aug; 58(4):458-66. PubMed ID: 8073515
[TBL] [Abstract][Full Text] [Related]
54. Characterization of anti-endothelial cell antibodies in the patients with systemic lupus erythematosus: a potential marker for disease activity.
Li JS; Liu MF; Lei HY
Clin Immunol Immunopathol; 1996 Jun; 79(3):211-6. PubMed ID: 8635277
[TBL] [Abstract][Full Text] [Related]
55. Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease.
Sahin S; Akoğlu T; Direskeneli H; Sen LS; Lawrence R
Ann Rheum Dis; 1996 Feb; 55(2):128-33. PubMed ID: 8712863
[TBL] [Abstract][Full Text] [Related]
56. New perspective on Behçet's disease.
Sakane T
Int Rev Immunol; 1997; 14(1):89-96. PubMed ID: 9203029
[TBL] [Abstract][Full Text] [Related]
57. Immunoglobulins G, M, A, D and E in Behcet's syndrome.
Scully C; Boyle P; Yap PL
Clin Chim Acta; 1982 Apr; 120(2):237-42. PubMed ID: 7067147
[TBL] [Abstract][Full Text] [Related]
58. Immunological aspects of recurrent oral ulceration and Behçet's syndrome.
Lehner T
J Oral Pathol; 1978; 7(6):424-30. PubMed ID: 105103
[TBL] [Abstract][Full Text] [Related]
59. Serum E-selectin and beta 2-microglobulin levels in Behçet's disease.
Karakuzu A; Aktaş A; Akçay F
J Int Med Res; 2002; 30(1):85-8. PubMed ID: 11921504
[TBL] [Abstract][Full Text] [Related]
60. Anti-endothelial cell antibodies in Behçet's disease.
Dinc A; Takafuta T; Jiang D; Melikoglu M; Saruhan-Direskeneli G; Shapiro SS
Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S27-30. PubMed ID: 14727455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
